Optometry Times Staff Reports

Chiesi Global Rare Diseases said the agency declined to approve its application and requested additional information for the proposed treatment of Leber hereditary optic neuropathy.

The planned study will assess the safety, efficacy, and optimal dosing of the investigational therapy in approximately 150 patients with DED.

According to the company, the lens is the first and only FDA-approved EDOF IOL in the US without a warning regarding loss of contrast sensitivity.

The study highlights the broader impact of OR on patients’ quality of life.

Amniotic membrane therapy has been used in refractory cases to protect the ocular surface, modulate inflammation and fibrosis, and promote epithelial healing.

The review notes aesthetic considerations are increasingly important as social media and video conferencing spotlight facial appearance.

Researchers examined 3 primary associations: the risk of developing uveitis following an IMID diagnosis, the odds of having a prior IMID among uveitis patients, and the risk of developing an IMID after a uveitis diagnosis.

The company said the expansions support its goal of making evidence-based myopia management accessible to eye care professionals and children worldwide.

The clinical study will evaluate a noninvasive corneal strengthening procedure designed to reshape the cornea and correct refractive errors in-office without tissue removal.

According to a VSP Vision Care news release, 71% say they experience performance impacts due to screen-related visual discomfort, equating to nearly one full workday of lost productivity each week.

Uveitis is a leading cause of blindness and accounts for an estimated 30,000 new cases of legal blindness annually in the US.

The monthly multifocal toric lens with novel water gradient material targets presbyopic patients with astigmatism and is available to eye care professionals nationwide.

ACP says the label “provider” blurs clinical roles, commercializes care, and erodes trust—urging words that protect medical ethics and relationships.

The study evaluated the company’s Defocus Incorporated Multiple Segments Triple Enhanced Design (DIMS TED) myopia control lenses in children aged 4–12 with progressive myopia.

The report estimates the industry’s total value at $69.5 billion.

Seventeen established and emerging eye care professionals from the United States and Canada were named as 2026 Visionaries.

The prospective observational study is being conducted across 18 countries.

The study included 144 patients with glaucoma or ocular hypertension who underwent 24-hour IOP monitoring between October 2023 and April 2024.

The lenses are commercially available in Canada as of February 2, 2026.

Nominations for the 2023 awards will close July 31, 2023.

The National Keratoconus Foundation has named NASCAR driver Joey Gase as Ambassador.

The annual conference will take place September 6-9 at the Renaissance Schaumburg Convention Center in Schaumburg, IL.

The organization now has chapters in Boston, San Antonio, New York, and Los Angeles.

Latinos En Optometry, also known as LEO, is launching and wants you to join their community as they expand membership, sponsorship, events, and engagement in the year ahead.

Kicking off AMD Awareness Month, give us your thoughts!